Immediate effects of active supine exercise associated with compression therapy on lower limb lymphedema

Immediate effects of active supine exercise associated with compression therapy on lower limb lymphedema - Immediate effects of active supine exercise associated with compression therapy on lower limb lymphedema

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000020129

Enrollment

Registered

2015-12-09

Start date

2016-01-25

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Patients with lower limb lymphedema

Interventions

A: To pedal the ergometer in a seated position with compression therapy for 15 minutes - Wash out period (1 week) - B: To pedal the ergometer in a supine position with compression therapy for 15 minut

Eligibility

Sex/Gender

Female

Inclusion criteria

Inclusion criteria: Patients with lower limb lymphedema Possible to perform active exercise Informed consent by her own will

Exclusion criteria

Exclusion criteria: Cellulitis, Lymphangitis, Erysipelas Leakage of lymphatic fluid Deep venous thrombosis and severe Aneurysm Poor general status Fever (37.0 degrees C) Sever heart disease Pulmonary embolism, acute respiratory failure, sever pulmonary hypertension within the past 3 months Sever hepatic or renal failure Other metabolic disorder (acute thyroiditis etc.) Pacemaker user

Design outcomes

Primary

Measure	Time frame
Evaluation period: Immediate pre -and - post intervention Outcome: Lower limb volume	—

Secondary

Measure	Time frame
Evaluation period: Immediate pre -and - post intervention 1:Pain(Visual Analogue Scale (VAS)) 2:Heaviness(Visual Analogue Scale (VAS)) 3:Pitting or non-pitting 4:Skin stiffness	—

Countries

Japan

Contacts

Public ContactKiriko Abe

Keio University Graduate School of Medicine Department of Rehabilitation Medicine

kirikirikiriko916@gmail.com03-5363-3833

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026